Utility, limitations and future of non-human primates for dengue research and vaccine development
Dengue is considered the most important emerging, human arboviruses, with worldwide distribution in the tropics. Unfortunately there are no licensed dengue vaccines available or specific antiviral drugs. The development of a dengue vaccine faces unique challenges. The 4 serotypes co-circulate in end...
Main Authors: | Laura eWhite, Carlos A Sariol |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2014-09-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fimmu.2014.00452/full |
Similar Items
-
Clinical development and regulatory points for consideration for second-generation live attenuated dengue vaccines
by: Vannice, Kirsten S., et al.
Published: (2018) -
Approaches of dengue control: vaccine strategies and future aspects
by: Runa Akter, et al.
Published: (2024-02-01) -
A rapid immunization strategy with a live attenuated tetravalent dengue vaccine elicits protective neutralizing antibody responses in non-human primates
by: Yuping eAmbuel, et al.
Published: (2014-06-01) -
Moving forward with Takeda's live chimeric tetravalent dengue vaccine
by: Wilder-Smith, Annelies
Published: (2017) -
Erratum on: A rapid immunization strategy with a live-attenuated tetravalent dengue vaccine elicits protective neutralizing antibody responses in non-human primates
by: Frontiers eProduction Office
Published: (2014-09-01)